NCT04429399

Brief Summary

The perfusion of the deeply different areas coexisting in ARDS lung generates two type of venus-admixure : true shunt and shunt effect. Briefly, true shunt and shunt effect are related to non-aerated and poorly-ventilated lung areas perfusion respectively. Practically, it is not possible to quantify the true shunt and the shunt-effect directly, but we can measure the "total-shunt", i.e. the sum of two kind of venus-admixured. As it is known from classical physiology, the effects of FiO2 variations on PaO2 are deeply different depending on the type of venous admixures. In the case of a patient with virtually only true shunt, any FiO2 variation will not modify the PaO2. On the other hand, in a patient with virtually only a shunt effect, increasing the FiO2 the PaO2 will progressively increase. Indeed, ventilating a patient presenting only a shunt effect (without true shunt) with pure oxygen will generate a "normal" P/F ratio. In patients ventilated with high PEEP levels it is difficult to predict based on the P/F ratio the relative amount of true shunt and shunt effect. However, patients presenting a significant shunt effect when ventilated with higher PEEP level would likely have "unstable" poorly aerated lung areas that need PEEP to remain opened. In those patients, a PEEP-weaning protocol based on the P/F ratio could induce significant alveolar de-recruitment and clinical deterioration. On the contrary, patients with less shunt effect would be likely less prone to alveolar de-recruitment and would benefice from PEEP decrease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 21, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

June 4, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 12, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

January 21, 2022

Status Verified

January 1, 2022

Enrollment Period

1.8 years

First QC Date

June 4, 2020

Last Update Submit

January 20, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • de-recruitment

    the shunt effect cold predict the lung de-recruitment volume

    decreasing PEEP from high to low levelthrough study completion, an average of 2 years

Study Arms (2)

High positive end-expiratory pressure Ventilation

OTHER

patient ventilated fixing high level of positive end expiratory pressure

Other: decrease the positive end expiratory pressure (PEEP)Other: mechanical features assessmentOther: shunt assessment

Low positive end-expiratory pressure Ventilation

OTHER

patient ventilated fixing low level of positive end expiratory pressure

Other: mechanical features assessmentOther: shunt assessment

Interventions

decrease the PEEP going from high (according to ExPress Trial) to low level

High positive end-expiratory pressure Ventilation

evaluation of the mechanical features of respiratory system

High positive end-expiratory pressure VentilationLow positive end-expiratory pressure Ventilation

evaluation of the pulmonary shunt during two different ventilation setting

High positive end-expiratory pressure VentilationLow positive end-expiratory pressure Ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age major than 18
  • days since the beginning of mechanical ventilation
  • Moderate or severe ARDS

You may not qualify if:

  • Patients with a story of chronic obstructive pulmonary disease (COPD)
  • Patients with asthma
  • Patients with neurological disease
  • Patients with heart disease
  • Patients with cardiopulmonary.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Azienda Ospedaliero Universitaria Policlinico

Bari, 70124, Italy

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 4, 2020

First Posted

June 12, 2020

Study Start

September 21, 2019

Primary Completion

June 21, 2021

Study Completion

January 1, 2022

Last Updated

January 21, 2022

Record last verified: 2022-01

Locations